Evidence map›Paper›PMID 37648417›Full record

ArticleArchives of disease in childhood. Fetal and neonatal edition2023

Parental perspectives about information and deferred versus two-stage consent in studies of neonatal asphyxia.

Christian A Maiwald, Charlotte Rovers, Annie Janvier, Heidrun Sturm, Martina Michaelis, Georg Marckmann, Hans-Joerg Ehni, Christian F Poets, Mario Rüdiger, Axel R Franz

Registry-linked trialAbstract read
In one paragraph

Article in Archives of disease in childhood. Fetal and neonatal edition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03162653 (Effect of ALlopurinol in Addition to Hypothermia for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a Blinded Randomized Placebo-controlled Parallel Group Multicenter Trial for Superiority), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03162653 phase3unknown statusnot on this map

Effect of ALlopurinol in Addition to Hypothermia for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a Blinded Randomized Placebo-controlled Parallel Group Multicenter Trial for Superiority (Phase III)

TypeinterventionalSponsorUniversity Hospital TuebingenRan2018 to 2026Enrolled760ConditionsEncephalopathy, Hypoxic-Ischemic, Infant, Newborn, DiseasesArmsAllopurinol, Mannitol
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Christian A MaiwaldDepartment of Neonatology, University Children's Hospital Tübingen, Tübingen, Baden-Württemberg, Germany Christian.Maiwald@med.uni-tuebingen.de.ORCID http://orcid.org/0000-0002-2240-6488
Charlotte RoversDepartment of Neonatology, University Children's Hospital Tübingen, Tübingen, Baden-Württemberg, Germany.
Annie JanvierDepartment of Pediatrics, Bureau de l'Éthique Clinique, Université de Montréal, Montreal, Québec, Canada.
Heidrun SturmCentre for Public Health and Health Services Research, Faculty of Medicine, University Hospital Tübingen, Tübingen, Baden-Württemberg, Germany.
Martina MichaelisCentre for Public Health and Health Services Research, Faculty of Medicine, University Hospital Tübingen, Tübingen, Baden-Württemberg, Germany.
Georg MarckmannInstitute of Ethics, History and Theory of Medicine, Ludwig Maximilians University (LMU) Munich, Munich, Bayern, Germany.
Hans-Joerg EhniInstitute for Ethics and History of Medicine, Medical Faculty, University of Tübingen, Tübingen, Baden-Württemberg, Germany.
Christian F PoetsDepartment of Neonatology, University Children's Hospital Tübingen, Tübingen, Baden-Württemberg, Germany.ORCID http://orcid.org/0000-0002-1072-0066
Mario RüdigerClinic for Pediatrics, Department of Neonatology and Pediatric Intensive Care, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Saxony, Germany.
Axel R FranzDepartment of Neonatology, University Children's Hospital Tübingen, Tübingen, Baden-Württemberg, Germany.ORCID http://orcid.org/0000-0001-5066-0857

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe ALBINO Trial (NCT03162653) investigates effects of very early postnatal allopurinol on neurocognitive outcome following perinatal asphyxia where prenatal informed consent (IC) is impossible. Ethically and legally, waiver of consent and/or deferred consent (DC) is acceptable in such an emergency. Short oral/two-step consent (SOC, brief information and oral consent followed by IC) has recently been investigated.

methodsMixed-methods analysis of parental opinions on DC versus SOC in the context of neonatal asphyxia in a survey at two German centres. Prospective parents (ProP), parents of healthy newborns (PNeo) and parents of asphyxiated infants (PAx) born between 2006 and 2016 were invited.

results108 of 422 parents participated (ProP:43; PNeo:35; PAx:30). Most parents trusted physicians, wanted preinterventional information and agreed that in emergencies interventions should begin immediately. Intergroup and intragroup variability existed for questions about DC and SOC. In the ALBINO Trial situation, 55% preferred SOC, and 26% reported DC without information might adversely affect their trust. Only 3% reported to potentially take legal action after DC. PAx were significantly more likely to support DC. PAx more frequently expressed positive emotions and appreciation for neonatal research. In open-ended questions, parents gave many constructive recommendations.

conclusionIn this survey, parents expressed diverse opinions on consent, but the majority preferred SOC over DC. Parents who had experienced emergency admission of their asphyxiated neonates were more trusting. Obtaining parental perspectives is essential when designing studies, while being cognisant that these groups of parents may not represent the opinion of all parents.

Indexed as

AsphyxiaAsphyxia NeonatorumFemaleHumansInfantInfant, NewbornInformed ConsentParental ConsentParentsPregnancyProspective StudiesEthicsNeonatology

Identifiers

PMID37648417
PMCPMC10804040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.